Monocarboxylate transporter 1 inhibitors as potential anticancer agents.
Basic Information
ID: ALA3580575
Journal: ACS Med Chem Lett
Title: Monocarboxylate transporter 1 inhibitors as potential anticancer agents.
Authors: Gurrapu S, Jonnalagadda SK, Alam MA, Nelson GL, Sneve MG, Drewes LR, Mereddy VR.
Abstract: Potent monocarboxylate transporter 1 inhibitors (MCT1) have been developed based on α-cyano-4-hydroxycinnamic acid template. Structure-activity relationship studies demonstrate that the introduction of p-N, N-dialkyl/diaryl, and o-methoxy groups into cyanocinnamic acid has maximal MCT1 inhibitory activity. Systemic toxicity studies in healthy ICR mice with few potent MCT1 inhibitors indicate normal body weight gains in treated animals. In vivo tumor growth inhibition studies in colorectal adenocarcinoma (WiDr cell line) in nude mice xenograft models establish that compound 27 exhibits single agent activity in inhibiting the tumor growth.
CiteXplore: 26005533
DOI: 10.1021/acsmedchemlett.5b00049
Patent ID: ┄